Milestone Pharmaceuticals Inc.
MIST
$1.51
-$0.13-7.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.02% | 8.05% | 37.55% | -67.93% | -30.98% |
| Total Depreciation and Amortization | 2,360.00% | -10.71% | 3.70% | -95.24% | 2,168.00% |
| Total Amortization of Deferred Charges | 5.50% | 2.83% | 3.92% | 5.15% | 2.11% |
| Total Other Non-Cash Items | 82.12% | -2.04% | 2.38% | 28.47% | -21.79% |
| Change in Net Operating Assets | 191.30% | 96.34% | -141.23% | 42.19% | 1,447.60% |
| Cash from Operations | -31.05% | 22.43% | 9.93% | -103.89% | 2.49% |
| Capital Expenditure | -14,050.00% | 81.82% | -83.33% | 72.73% | -450.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 108.54% | -451.40% | -70.36% | 73.53% | 198.47% |
| Cash from Investing | 107.73% | -451.81% | -70.39% | 73.70% | 198.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.39% | 128,636.11% | -74.29% | 483.33% | -67.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -25.52% | 135,783.33% | -74.29% | 483.33% | -67.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 529.74% | 261.87% | -113.08% | 57.98% | 2,803.02% |